1. Home
  2. IRIX vs ASBP Comparison

IRIX vs ASBP Comparison

Compare IRIX & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • ASBP
  • Stock Information
  • Founded
  • IRIX 1989
  • ASBP 2021
  • Country
  • IRIX United States
  • ASBP United States
  • Employees
  • IRIX N/A
  • ASBP N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ASBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRIX Health Care
  • ASBP Health Care
  • Exchange
  • IRIX Nasdaq
  • ASBP Nasdaq
  • Market Cap
  • IRIX 16.5M
  • ASBP 17.6M
  • IPO Year
  • IRIX 1996
  • ASBP N/A
  • Fundamental
  • Price
  • IRIX $1.01
  • ASBP $0.25
  • Analyst Decision
  • IRIX Hold
  • ASBP
  • Analyst Count
  • IRIX 1
  • ASBP 0
  • Target Price
  • IRIX $2.00
  • ASBP N/A
  • AVG Volume (30 Days)
  • IRIX 80.7K
  • ASBP 473.2K
  • Earning Date
  • IRIX 05-13-2025
  • ASBP 05-28-2025
  • Dividend Yield
  • IRIX N/A
  • ASBP N/A
  • EPS Growth
  • IRIX N/A
  • ASBP N/A
  • EPS
  • IRIX N/A
  • ASBP N/A
  • Revenue
  • IRIX $48,804,000.00
  • ASBP N/A
  • Revenue This Year
  • IRIX $9.61
  • ASBP N/A
  • Revenue Next Year
  • IRIX N/A
  • ASBP N/A
  • P/E Ratio
  • IRIX N/A
  • ASBP N/A
  • Revenue Growth
  • IRIX N/A
  • ASBP N/A
  • 52 Week Low
  • IRIX $0.78
  • ASBP $0.32
  • 52 Week High
  • IRIX $3.25
  • ASBP $15.80
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 40.50
  • ASBP N/A
  • Support Level
  • IRIX $0.98
  • ASBP N/A
  • Resistance Level
  • IRIX $1.19
  • ASBP N/A
  • Average True Range (ATR)
  • IRIX 0.06
  • ASBP 0.00
  • MACD
  • IRIX -0.02
  • ASBP 0.00
  • Stochastic Oscillator
  • IRIX 8.57
  • ASBP 0.00

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About ASBP Aspire Biopharma Holdings Inc. Common Stock

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: